| 今开：9.41 | 昨收：9.22 |
| 最高：9.56 | 最低：9.21 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.040947492E9 |
Cogent Biosciences(COGT)05-07 20:35
$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-053977 Act: 34 Size: 6 MB 网页链接查看全文
Cogent Biosciences(COGT)06-13 18:15
$Cogent Biosciences(COGT)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-24-160264 Act: 34 Size: 53 KB 网页链接查看全文
Cogent Biosciences(COGT)05-07 20:25
$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-053974 Act: 34 Size: 382 KB 网页链接查看全文
Cogent Biosciences(COGT)05-30 04:05
$Cogent Biosciences(COGT)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-24-065891 Size: 14 KB 网页链接查看全文
Cogent Biosciences(COGT)06-14 07:15
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-073226 Size: 5 KB 网页链接查看全文
Cogent Biosciences(COGT)06-27 20:15
$Cogent Biosciences(COGT)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-24-169756 Act: 34 Size: 164 KB 网页链接查看全文
Cogent Biosciences(COGT)06-13 09:05
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-072639 Size: 9 KB 网页链接查看全文
Cogent Biosciences(COGT)06-14 07:15
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-073234 Size: 5 KB 网页链接查看全文
Cogent Biosciences(COGT)06-14 07:25
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-073238 Size: 5 KB 网页链接查看全文
Cogent Biosciences(COGT)06-14 07:25
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-073235 Size: 5 KB 网页链接查看全文
Cogent Biosciences(COGT)宣布已开始承销公开发行1.25亿美元的普通股。Cogent打算将此次发行的净收益用于与bezuclastinib和其他候选产品相关的开发、监管和商业准备活动，以及营运资金和一般公司用途。Jefferies、Piper Sandler& Co.和Gugge... 网页链接
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-080555 Size: 5 KB 网页链接
$Cogent Biosciences(COGT)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-24-169756 Act: 34 Size: 164 KB 网页链接
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-073235 Size: 5 KB 网页链接
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-073238 Size: 5 KB 网页链接
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-073226 Size: 5 KB 网页链接
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-073228 Size: 5 KB 网页链接
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-073231 Size: 5 KB 网页链接
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-073234 Size: 5 KB 网页链接
$Cogent Biosciences(COGT)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-24-160264 Act: 34 Size: 53 KB 网页链接
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-072639 Size: 9 KB 网页链接